Skip To Content

ACD/Labs Blog

Joel Michalski
Watch the recordings from our Virtual LC & MS Symposium featuring speakers from the pharmaceutical, medical-device, and lab-software industries discussing how they map their separation spaces, automate their data processing, build databases, and more.

Charis Lam
ACD/Labs is launching a new podcast! The Analytical Wavelength will cover industry trends and topics for scientists working with analytical data. Read on for more insights about data and the mass spectrometrist, and a link to listen to Episode 1.

Joel Michalski
This webinar on ACD/MS Fragmenter will show you how to predict mass fragments based on chemical structure and match the prediction to your spectrum. Join us to learn more about how MS Fragmenter can support your spectral interpretation.

Joel Michalski
The knowledge generated in metabolite identification studies can provide valuable insights for intelligent drug design, and the maximum value from these studies can be harvested only if the data are stored and easily accessible within the organization. Similarly, synthetic reactions, forced degradation/stability studies, impurity identification, structural characterization, environmental stability studies and many other activities generate...

Joel Michalski
Improvements in mass spectrometry have generated an increasing demand for analysis of more complicated samples by mass spectrometry (MS). While liquid chromatography (LC) and gas chromatography (GC) are effective at reducing sample complexity, co-elution of components is still not entirely avoidable. The reality of today’s lab is: A variety of instrument configurations and a multitude...

Joel Michalski
Current deformulation scientists face MASSive exSPECtations—they are required to detect, screen, and identify unknowns with increasing efficiency despite shrinking analytical group sizes, pressure to perform more diverse activities, increased outsourcing of work, and slow, tedious, and error-prone methods. As a result analysts are left with much less time to devote to complex deformulation projects, while...

Joel Michalski
Amgen purifies approximately 5000 compounds per year in biotech/pharmaceutical discovery, with LC/MS analysis and purity reporting serving as key final steps in this process. In collaboration with ACD/Labs, they have generated automation processes which reduce time for report generation and review. Join us to learn about the benefits of the LC/MS automation workflow, including report...

Joel Michalski
Current metabolite identification (MetID) scientists face MASSive exSPECtations—they are required to detect and identify metabolites with increasing efficiency despite shrinking analytical group sizes, pressure to perform more diverse activities, increased outsourcing of work, and slow, tedious, and error-prone methods. As a result analysts are left with much less time to devote to complex MetID projects,...